Alicia N. Pepper
Alicia N. Pepper publishes mostly in Economics and Econometrics, Infectious Diseases and Epidemiology, on topics such as COVID-19 Clinical Research Studies, Health Systems, Economic Evaluations, Quality of Life and Intensive Care Unit Cognitive Disorders.
- World rank
- #5,870,454 of 7,710,434 ranked researchers
- Rank in Canada
- #163,709 of 183,316
- Works
- 15
- Citations
- 54
- Citations per work
- 3.6
What does Alicia N. Pepper research?
Alicia N. Pepper's work is mostly in Medicine (31%), Economics, Econometrics and Finance (16%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else637.7%
- Health Sciences531.1%
- Medicine531.1%
- Life Sciences215.6%
- Social Sciences215.6%
- 1Economics and Econometrics16% of their works
- 2Infectious Diseases11% of their works
- 3Epidemiology11% of their works
- 4Molecular Biology9% of their works
- 5Neurology9% of their works
- 6Plant Science7% of their works
Research topics
- COVID-19 Clinical Research Studies
- Health Systems, Economic Evaluations, Quality of Life
- Intensive Care Unit Cognitive Disorders
- Neuroendocrine Tumor Research Advances
- Inflammatory Myopathies and Dermatomyositis
- Long-Term Effects of COVID-19
- Neuroblastoma Research and Treatments
- Systemic Sclerosis and Related Diseases
Which keywords describe Alicia N. Pepper's research?
The keywords of their largest research topics: Autoantibodies, Clinical Characteristics, Cost-effectiveness Analysis, Genetic Mutations, Quality of Life, SARS-CoV-2, Treatment and ALK.
- Post-acute COVID-19 Syndrome
- Neurologic Manifestations
- Neuroblastoma
- Inflammatory Myopathies
- Dermatomyositis
- ALK
- SARS-CoV-2
- Genetic Mutations
- Clinical Characteristics
- Autoantibodies
- Cost-effectiveness Analysis
- Quality of Life
- Treatment
- Delirium
- Fibrosis
- Intensive Care Unit
- Neuroendocrine Tumors
- Pancreatic Neuroendocrine Tumors
- Systemic Sclerosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Autoantibodies42 topics
- Clinical Characteristics41 topic
- Cost-effectiveness Analysis41 topic
- Genetic Mutations42 topics
- Quality of Life41 topic
- SARS-CoV-241 topic
- Treatment42 topics
- ALK21 topic
- Delirium21 topic
- Dermatomyositis21 topic
- Fibrosis21 topic
- Inflammatory Myopathies21 topic
- Intensive Care Unit21 topic
- Neuroblastoma21 topic
- Neuroendocrine Tumors21 topic
- Neurologic Manifestations21 topic
- Pancreatic Neuroendocrine Tumors21 topic
- Post-acute COVID-19 Syndrome21 topic
- Systemic Sclerosis21 topic
Where does Alicia N. Pepper work?
Alicia N. Pepper's main affiliation in the publication record is EVERSANA (Canada), Canada.
How many publications and citations does Alicia N. Pepper have?
OpenAlex counts 15 works and 54 citations for Alicia N. Pepper, an h-index of 5, ranking #5,870,454 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Alicia N. Pepper. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.